Ilgaz Aydinlar Elif, Yalinay Dikmen Pınar, Sağduyu Kocaman Ayşe
Acıbadem University, Medical Faculty, Department of Neurology, İstanbul, Turkey.
Noro Psikiyatr Ars. 2013 Aug;50(Suppl 1):S36-S40. doi: 10.4274/npa.y7198. Epub 2013 Aug 1.
Since botulinum toxin might have a therapeutic effect on pain, many studies investigating the efficiency of botulinum toxin in headache treatment have been done. The most satisfying results were achieved by botulinum toxin type A (BoNT/A) in the treatment of chronic migraine. In this paper, we reviewed the clinical effectiveness of BoNT/A in migraine and included our clinical experience. In our ongoing pilot study, where we have repeated BoNT/A injections every 12 weeks, The difference in the Migraine Disability Assessment (MIDAS) scores between the first and the second injections was 61.1%; and between the first and the 3rd injections was found to be 65.72%.
由于肉毒杆菌毒素可能对疼痛具有治疗作用,因此已经开展了许多研究来调查肉毒杆菌毒素在头痛治疗中的效果。A型肉毒杆菌毒素(BoNT/A)在慢性偏头痛治疗中取得了最令人满意的结果。在本文中,我们回顾了BoNT/A在偏头痛治疗中的临床疗效,并纳入了我们的临床经验。在我们正在进行的初步研究中,我们每12周重复注射BoNT/A,首次注射与第二次注射之间的偏头痛残疾评估(MIDAS)评分差异为61.1%;首次注射与第三次注射之间的差异为65.72%。